Related Experiment Videos
Conservative therapy for malignant struma ovarii. A case report.
Patricia A Nahn1, Emily Robinson, Michael Strassman
1Departments of Obstetrics and Gynecology, and Hematology/Oncology and Laboratory Services, Mercy Health System, Janesville, Wisconsin, USA.
The Journal of Reproductive Medicine
|December 25, 2002
Summary
Malignant struma ovarii, a rare thyroid cancer in ovarian teratomas, can be treated conservatively. Fertility-sparing surgery is a viable option for women desiring future pregnancy.
Area of Science:
- Gynecologic Oncology
- Endocrinology
- Pathology
Background:
- Struma ovarii is a rare germ cell tumor containing thyroid tissue.
- Thyrocarcinoma within struma ovarii presents unique diagnostic and therapeutic challenges.
- Standard treatments may involve extensive surgery and adjuvant therapies, potentially impacting fertility.
Observation:
- A case of a young woman presenting with a pelvic mass.
- Diagnostic workup revealed malignant thyroid tissue consistent with thyrocarcinoma.
- Initial surgical management involved unilateral salpingo-oophorectomy.
Findings:
- The patient was diagnosed with malignant struma ovarii.
- No adjuvant therapy was administered post-operatively.
- Histopathological examination confirmed the presence of thyroid carcinoma.
Implications:
- Conservative surgical management, such as unilateral salpingo-oophorectomy, can be considered for malignant struma ovarii.
- Preserving fertility is a key consideration in managing these rare tumors.
- Further research into fertility-sparing approaches for malignant struma ovarii is warranted.